New alert via PocketInfo for PLX:
Protalix BioTherapeutics Announces Positive Interim Results from Phase II Clinical Trial of alidornase alfa (AIR DNaseTM) for the Treatment of Cystic Fibrosis
Press Releases: http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-news
SEC Filings: http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8
No comments:
Post a Comment